-
Je něco špatně v tomto záznamu ?
Creation of arteriovenous fistula for hemodialysis in the older population
M. Medricka, J. Janeckova, J. Jarosciakova, P. Bachleda
Jazyk angličtina Země Česko
Typ dokumentu časopisecké články
NLK
Directory of Open Access Journals
od 2001
Free Medical Journals
od 1998
Medline Complete (EBSCOhost)
od 2007-06-01
ROAD: Directory of Open Access Scholarly Resources
od 2001
PubMed
32285849
DOI
10.5507/bp.2020.013
Knihovny.cz E-zdroje
- MeSH
- arteriovenózní píštěl * MeSH
- arteriovenózní zkrat * MeSH
- časové faktory MeSH
- chronické selhání ledvin * MeSH
- dialýza ledvin MeSH
- lidé MeSH
- okluze cévního štěpu etiologie MeSH
- průchodnost cév MeSH
- retrospektivní studie MeSH
- senioři MeSH
- výsledek terapie MeSH
- Check Tag
- lidé MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
OBJECTIVE: To evaluate the results of arteriovenous fistula (AVF) created for haemodialysis in patients older than 65 years of age. SUBJECTS AND METHODS: A retrospective analysis of patients with AVF or arteriovenous graft (AVG) creation, who were older than 65 years of age and were operated on at the II. Surgical Clinic at the University Hospital in Olomouc from 2014 - 2018 was performed. RESULTS: 212 patients were evaluated and a total of 239 AVF/AVG were created. 194 AVFs (81.18%) and 45 AVGs (18.82%) were created. Primary failure was seen in 19 arteriovenous fistulas (9.8%) and 2 arteriovenous grafts (4.44%). The primary patency of AVF was 69.9%, 62.8% after 12 and 24 months, respectively, and in the case of AVG it was 54.7% and 32.3% after 12 and 24 months, respectively. Primarily assisted patency of AVF was 77.6% and 66.3% after 12 and 24 months, respectively, and in case of AVG it was 69.1% and 39.7% after 12 and 24 months, respectively. Secondary patency of AVF was 77.6% and 66.3% after 12 and 24 months, respectively, and for AVG it was 69.1% and 39.7% after 12 and 24 months, respectively. CONCLUSION: The type of vascular access should be selected based on a thorough, protocol-based examination. In most seniors, AVF is the method of choice. The AVG is a suitable choice for patients with an exhausted venous bed, in acute need of haemodialysis, in the elderly and in females. A "customized" approach should be matter of fact for older generations.
Citace poskytuje Crossref.org
Literatura
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22007874
- 003
- CZ-PrNML
- 005
- 20220406132231.0
- 007
- ta
- 008
- 220309s2021 xr f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.5507/bp.2020.013 $2 doi
- 035 __
- $a (PubMed)32285849
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Medřická, Monika $7 xx0250098 $u Department of Vascular and Transplantation Surgery, University Hospital Olomouc, Czech Republic
- 245 10
- $a Creation of arteriovenous fistula for hemodialysis in the older population / $c M. Medricka, J. Janeckova, J. Jarosciakova, P. Bachleda
- 504 __
- $a Literatura
- 520 9_
- $a OBJECTIVE: To evaluate the results of arteriovenous fistula (AVF) created for haemodialysis in patients older than 65 years of age. SUBJECTS AND METHODS: A retrospective analysis of patients with AVF or arteriovenous graft (AVG) creation, who were older than 65 years of age and were operated on at the II. Surgical Clinic at the University Hospital in Olomouc from 2014 - 2018 was performed. RESULTS: 212 patients were evaluated and a total of 239 AVF/AVG were created. 194 AVFs (81.18%) and 45 AVGs (18.82%) were created. Primary failure was seen in 19 arteriovenous fistulas (9.8%) and 2 arteriovenous grafts (4.44%). The primary patency of AVF was 69.9%, 62.8% after 12 and 24 months, respectively, and in the case of AVG it was 54.7% and 32.3% after 12 and 24 months, respectively. Primarily assisted patency of AVF was 77.6% and 66.3% after 12 and 24 months, respectively, and in case of AVG it was 69.1% and 39.7% after 12 and 24 months, respectively. Secondary patency of AVF was 77.6% and 66.3% after 12 and 24 months, respectively, and for AVG it was 69.1% and 39.7% after 12 and 24 months, respectively. CONCLUSION: The type of vascular access should be selected based on a thorough, protocol-based examination. In most seniors, AVF is the method of choice. The AVG is a suitable choice for patients with an exhausted venous bed, in acute need of haemodialysis, in the elderly and in females. A "customized" approach should be matter of fact for older generations.
- 650 _2
- $a senioři $7 D000368
- 650 12
- $a arteriovenózní píštěl $7 D001164
- 650 12
- $a arteriovenózní zkrat $7 D001166
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a okluze cévního štěpu $x etiologie $7 D006083
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a chronické selhání ledvin $7 D007676
- 650 _2
- $a dialýza ledvin $7 D006435
- 650 _2
- $a retrospektivní studie $7 D012189
- 650 _2
- $a časové faktory $7 D013997
- 650 _2
- $a výsledek terapie $7 D016896
- 650 _2
- $a průchodnost cév $7 D014654
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Janečková, Jana, $d 1982- $7 xx0227477 $u Department of Vascular and Transplantation Surgery, University Hospital Olomouc, Czech Republic
- 700 1_
- $a Jaroščiaková, Julia $7 xx0271370 $u Department of Vascular and Transplantation Surgery, University Hospital Olomouc, Czech Republic
- 700 1_
- $a Bachleda, Petr, $d 1954- $7 jn20020716344 $u Department of Vascular and Transplantation Surgery, University Hospital Olomouc, Czech Republic
- 773 0_
- $w MED00012606 $t Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia $x 1213-8118 $g Roč. 165, č. 2 (2021), s. 179-183
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/32285849 $y Pubmed
- 910 __
- $a ABA008 $b A 1502 $c 958 $y p $z 0
- 990 __
- $a 20220309 $b ABA008
- 991 __
- $a 20220406132226 $b ABA008
- 999 __
- $a ok $b bmc $g 1775511 $s 1159067
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 165 $c 2 $d 179-183 $e 20200407 $i 1213-8118 $m Biomedical papers of the Medical Faculty of the University Palacký, Olomouc Czech Republic $n Biomed. Pap. Fac. Med. Palacký Univ. Olomouc Czech Repub. (Print) $x MED00012606
- LZP __
- $b NLK118 $a Pubmed-20220309